While waves of change diffused across psychedelic science and research policy in Texas, bills such as Senate Bill (SB) 3 made cannabis research and medical cannabis access infinitely more difficult when it had already been a slog. I don’t know when cannabis was exiled from its psychedelic family, but a plant with a wider net […]

The post Does Cannabis Research Deserve As Much Funding As Ibogaine Research? appeared first on Psychedelics Today.

Previous articleMay 2025 Psychedelic Patent Update: Gilgamesh Broadens Moat Around Lead Candidate Following Positive Phase 2a Readout; Lykos Publishes Further Continuation Applications; Reconnect Joins Crowded 5-MeO-DMT Patent Landscape